Hall, Bradford E.
Macdonald, Emma
Cassidy, Margaret
Yun, Sijung
Sapio, Matthew R.
Ray, Pradipta
Doty, Megan
Nara, Pranavi
Burton, Michael D.
Shiers, Stephanie
Ray-Chaudhury, Abhik
Mannes, Andrew J.
Price, Theodore J.
Iadarola, Michael J.
Kulkarni, Ashok B.
Funding for this research was provided by:
National Institutes of Health, USA (ZIA-DE-000664-24)
National Institutes of Health, USA (ZIA-DE-000664-24)
National Institutes of Health, USA (ZIA-DE-000664-24)
National Institutes of Health, USA (ZIA-DE-000664-24)
National Institutes of Health, USA (ZIA-DE-000664-24)
National Institutes of Health, USA (ZIA-DE-000664-24)
NIH Clinical Center (1ZIACL090033-08 and 1ZIACL090035-07)
NIH Clinical Center (1ZIACL090033-08 and 1ZIACL090035-07)
NIH Clinical Center (1ZIACL090033-08 and 1ZIACL090035-07)
NIH Clinical Center (1ZIACL090033-08 and 1ZIACL090035-07)
NIH Clinical Center (1ZIACL090033-08 and 1ZIACL090035-07)
Office of Extramural Research, National Institutes of Health (NS111929)
Office of Extramural Research, National Institutes of Health (NS111929)
Office of Extramural Research, National Institutes of Health (NS111929)
Office of Extramural Research, National Institutes of Health (NS111929)
National Institutes of Health
Article History
Received: 8 October 2021
Accepted: 25 February 2022
First Online: 18 March 2022
Competing interests
: All authors have declared that no conflict of interest exists. TJP is a co-founder of Doloromics, a company developing novel pain therapeutics. Doloromics played no role in this study.